These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 17578674)
21. Evaluation of blood-brain barrier and blood-cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models. Hu HH; Bian YC; Liu Y; Sheng R; Jiang HD; Yu LS; Hu YZ; Zeng S Int J Pharm; 2014 Jan; 460(1-2):101-7. PubMed ID: 24262988 [TBL] [Abstract][Full Text] [Related]
22. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082 [TBL] [Abstract][Full Text] [Related]
23. Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells. Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM Antimicrob Agents Chemother; 2007 Aug; 51(8):2748-57. PubMed ID: 17548493 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model. Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473 [TBL] [Abstract][Full Text] [Related]
25. Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. Goh LB; Spears KJ; Yao D; Ayrton A; Morgan P; Roland Wolf C; Friedberg T Biochem Pharmacol; 2002 Dec; 64(11):1569-78. PubMed ID: 12429346 [TBL] [Abstract][Full Text] [Related]
26. Characterisation of P-glycoprotein-9.1 in Haemonchus contortus. Godoy P; Che H; Beech RN; Prichard RK Parasit Vectors; 2016 Jan; 9():52. PubMed ID: 26822677 [TBL] [Abstract][Full Text] [Related]
27. Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cells. Fahrmayr C; König J; Auge D; Mieth M; Fromm MF Br J Pharmacol; 2012 Mar; 165(6):1836-1847. PubMed ID: 21923755 [TBL] [Abstract][Full Text] [Related]
28. Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? Tang F; Horie K; Borchardt RT Pharm Res; 2002 Jun; 19(6):773-9. PubMed ID: 12134946 [TBL] [Abstract][Full Text] [Related]
29. Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells. Lowes S; Simmons NL Br J Pharmacol; 2002 Mar; 135(5):1263-75. PubMed ID: 11877335 [TBL] [Abstract][Full Text] [Related]
30. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers. Zhang Y; Benet LZ Pharm Res; 1998 Oct; 15(10):1520-4. PubMed ID: 9794492 [TBL] [Abstract][Full Text] [Related]
31. Comparison of drug efflux transport kinetics in various blood-brain barrier models. Bachmeier CJ; Trickler WJ; Miller DW Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372 [TBL] [Abstract][Full Text] [Related]
32. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Videmann B; Tep J; Cavret S; Lecoeur S Food Chem Toxicol; 2007 Oct; 45(10):1938-47. PubMed ID: 17543436 [TBL] [Abstract][Full Text] [Related]
33. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein. Zhang C; Kwan P; Zuo Z; Baum L Life Sci; 2010 Jun; 86(23-24):899-905. PubMed ID: 20417647 [TBL] [Abstract][Full Text] [Related]
34. Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Michaelis M; Rothweiler F; Klassert D; von Deimling A; Weber K; Fehse B; Kammerer B; Doerr HW; Cinatl J Cancer Res; 2009 Jan; 69(2):416-21. PubMed ID: 19147553 [TBL] [Abstract][Full Text] [Related]
35. Expressions of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in lung dendritic cells. Hasegawa H; Inui N; Suda T; Shibata K; Nakamura Y; Watanabe H; Nakamura H; Chida K Life Sci; 2011 Aug; 89(7-8):282-7. PubMed ID: 21763326 [TBL] [Abstract][Full Text] [Related]
36. Transport studies with 5-aminosalicylate. Xin HW; Schwab M; Klotz U Eur J Clin Pharmacol; 2006 Oct; 62(10):871-5. PubMed ID: 16944117 [TBL] [Abstract][Full Text] [Related]
37. Flow cytometric assessment of P-glycoprotein and multidrug resistance-associated protein activity and expression in canine lymphoma. Poźniak B; Pawlak A; Obmińska-Mrukowicz B In Vivo; 2015; 29(1):149-53. PubMed ID: 25600546 [TBL] [Abstract][Full Text] [Related]
38. A modified coumarinic acid-based cyclic prodrug of an opioid peptide: its enzymatic and chemical stability and cell permeation characteristics. Ouyang H; Tang F; Siahaan TJ; Borchardt RT Pharm Res; 2002 Jun; 19(6):794-801. PubMed ID: 12134949 [TBL] [Abstract][Full Text] [Related]
39. Role of P-glycoprotein in the disposition of macrocyclic lactones: A comparison between ivermectin, eprinomectin, and moxidectin in mice. Kiki-Mvouaka S; Ménez C; Borin C; Lyazrhi F; Foucaud-Vignault M; Dupuy J; Collet X; Alvinerie M; Lespine A Drug Metab Dispos; 2010 Apr; 38(4):573-80. PubMed ID: 20089736 [TBL] [Abstract][Full Text] [Related]
40. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers. Siccardi D; Kandalaft LE; Gumbleton M; McGuigan C J Pharmacol Exp Ther; 2003 Dec; 307(3):1112-9. PubMed ID: 14557377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]